SharmilaMakhijaMDMBA

PubMed

• Risk factors associated with delayed discharge following robotic assisted surgery for gynecologic malignancy.
  Joan Tymon-Rosario, D.T. Miller, Akiva P. Novetsky, Gary L. Goldberg, Nicole S. Nevadunsky, Sharmila K. Makhija, Dennis Yi-Shin Kuo, Anne Van Arsdale> ;Gynecologic Oncology. 2020 Mar 23
• 5 citations
  Racial Differences in Survival From Epithelial Ovarian Cancer Are Associated With Stage at Diagnosis and Use of Neoadjuvant Therapy: A 10-Year Single-Institution Exper...
  Eirwen M. Miller, Joan Tymon-Rosario, Howard D. Strickler, Xianhong Xie, Xiaonan Xue, Dennis Yi-Shin Kuo, Sharmila K. Makhija, Nicole S. Nevadunsky> ;International Journal of Gynecological Cancer. 2018 May 1
• 124 citations
  Clinical Activity of Gemcitabine Plus Pertuzumab in Platinum-Resistant Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
  Sharmila Makhija, Lukas C. Amler, Dana Glenn, Frederick R. Ueland, Michael A. Gold, Don S. Dizon, Virginia E. Paton, Chin Yu Lin, Thomas Januario, Kimmie Ng, Andreas S...> ;Journal of Clinical Oncology. 2010 Mar 1
• 1 citations
  HER dimerization inhibitors: developing pertuzumab as an anticancer agent in women's oncology.
  Don S. Dizon, Sharmila Makhija> ;Expert Opinion on Drug Discovery. 2008 Oct 22
• HER pathway gene expression analysis in a phase II study of pertuzumab + gemcitabine vs. gemcitabine + placebo in patients with platinum-resistant epithelial ovarian c...
  Amler L, Makhija S, Januario T, Matulonis UA, Strauss A, Dizon DS, Sliwkowski MX, Dolezal M, Tong B, Paton V> ;J. Clin. Oncol.. 2008-05-20
• 16 citations
  Improved anti-tumor therapy based upon infectivity enhanced adenoviral delivery of RNA interference in ovarian carcinoma cell lines
  T. Michael Numnum, Sharmila K. Makhija, Baogen Lu, Minghui Wang, Angel A. Rivera, Mariam A. Stoff-Khalili, Ronald D. Alvarez, Zeng Bian Zhu, David T. Curiel> ;Gynecologic Oncology. 2008 Jan 1
• 11 citations
  Targeting of a conditionally replicative adenovirus agent to human squamous cell carcinomas of the head and neck.
  Zeng B. Zhu, J. Michael Mathis, Sharmila K. Makhija, Baogen Lu, Minghui Wang, Shaonin Ji, Angel A. Rivera, Eben L. Rosenthal, Gene P. Siegal, David T. Curiel> ;International Journal of Oncology. 2007 Nov 1
• 26 citations
  Treatment of ovarian cancer with a novel dual targeted conditionally replicative adenovirus (CRAd).
  Rodney P. Rocconi, Zeng B. Zhu, Mariam A. Stoff-Khalili, Angel A. Rivera, Baogen Lu, Minghui Wang, Ronald D. Alvarez, David T. Curiel, Sharmila K. Makhija> ;Gynecologic Oncology. 2007 Apr 1
• 32 citations
  Identifying the safety profile of a novel infectivity-enhanced conditionally replicative adenovirus, Ad5-Δ24-RGD, in anticipation of a phase I trial for recurrent ovar...
  John G. Page, Baohong Tian, Karen Schweikart, Joseph E. Tomaszewski, Raymond D. Harris, Trevor Broadt, Judith Polley-Nelson, Patricia E. Noker, Minghui Wang, Sharmila ...> ;American Journal of Obstetrics and Gynecology. 2007 Apr 1
• 8 citations
  Targeting lung cancer using an infectivity enhanced CXCR4-CRAd
  Zeng B. Zhu, Angel A. Rivera, Sharmila K. Makhija, Baogen Lu, Minghui Wang, Miiru Izumi, Mariam A. Stoff-Khalili, Fen Zhou, Koichi Takayama, Gene P. Siegal, David T. C...> ;Lung Cancer. 2007 Feb 1
• 2 citations
  Icodextrin enhances survival in an intraperitoneal ovarian cancer murine model utilizing gene therapy.
  Rodney P. Rocconi, Michael T. Numnum, Zeng B. Zhu, Baogen Lu, Minghui Wang, Angel A. Rivera, Mariam A. Stoff-Khalili, Ronald D. Alvarez, David T. Curiel, Sharmila K. M...> ;Gynecologic Oncology. 2006 Dec 1
• 35 citations
  Survivin promoter-based conditionally replicative adenoviruses target cholangiocarcinoma
  Zeng Bian Zhu, Yabing Chen, Sharmila K. Makhija, Baogen Lu, Minghui Wang, Angel A. Rivera, Masato Yamamoto, Shuyi Wang, Gene P. Siegal, David T. Curiel, Jay M. McDonald> ;International Journal of Oncology. 2006 Nov 1
• 25 citations
  Targeting mesothelioma using an infectivity enhanced survivin-conditionally replicative adenoviruses.
  Zeng B. Zhu, Sharmila K. Makhija, Baogen Lu, Minghui Wang, Shuyi Wang, Koichi Takayama, Gene P. Siegal, Paul N. Reynolds, David T. Curiel> ;Journal of Thoracic Oncology. 2006 Sep 1
• 52 citations
  Inducible resistance of tumor cells to tumor necrosis factor-related apoptosis-inducing ligand receptor 2-mediated apoptosis by generation of a blockade at the death d...
  Yang Li, Hong Wang, Zheng Wang, Sharmila K. Makhija, Donald J. Buchsbaum, Albert F. LoBuglio, Robert P. Kimberly, Tong Zhou> ;Cancer Research. 2006 Sep 1
• A randomized phase II trial with gemcitabine with or without pertuzumab (rhuMAb 2C4) in platinum-resistant ovarian cancer (OC): Preliminary safety data.
  Glenn D, Ueland F, Bicher A, Dizon D, Gold M, Makhija S, Fleming GF, Matulonis U, McGuire WP, Lieberman G> ;J. Clin. Oncol.. 2006-06-20
• 19 citations
  Targeted Gene Therapy for Ovarian Cancer
  Rodney P. Rocconi, T. Michael Numnum, Mariam A. Stoff-Khalili, Sharmila K. Makhija, Ronald D. Alvarez, David T. Curiel> ;Current Gene Therapy. 2005 Nov 30
• 36 citations
  Incorporating the survivin promoter in an infectivity enhanced CRAd-analysis of oncolysis and anti-tumor effects in vitro and in vivo
  Zeng B. Zhu, Sharmila K. Makhija, Baogen Lu, Minghui Wang, Angel A. Rivera, SangAe Kim-Park, Ilya V. Ulasov, Fen Zhou, Ronald D. Alvarez, Gene P. Siegal, David T. Curiel> ;International Journal of Oncology. 2005 Jul 1
• 41 citations
  Evaluation of tumor-specific promoter activities in melanoma
  Baogen Lu, Sharmila K. Makhija, Dirk M. Nettelbeck, Angel A. Rivera, M. Wang, Svetlana Komarova, Fen Zhou, Masato Yamamoto, Hidde J. Haisma, Ronald D. Alvarez, David T...> ;Gene Therapy. 2005 Feb 1
• 5 citations
  Double jeopardy: HIV and cervical cancer in Indian women.
  Vikrant V. Sahasrabuddhe, Sharmila K. Makhija> ;International Journal of Gynecological Cancer. 2005 Jan 1
• 31 citations
  Transport across a polarized monolayer of Caco-2 cells by transferrin receptor-mediated adenovirus transcytosis.
  Zeng B. Zhu, Sharmila K. Makhija, Baogen Lu, Minghui Wang, Angel A. Rivera, Meredith A. Preuss, Fen Zhou, Gene P. Siegal, Ronald D. Alvarez, David T. Curiel> ;Virology. 2004 Jul 20
• 79 citations
  Transcriptional targeting of tumors with a novel tumor-specific survivin promoter.
  Zeng B. Zhu, Sharmila K. Makhija, Baogen Lu, Minghui Wang, Lioudmila Kaliberova, Bin Liu, Angel A. Rivera, Dirk M. Nettelbeck, Parameshwar J. Mahasreshti, Charles A. L...> ;Cancer Gene Therapy. 2004 Apr 1
• 48 citations
  Transcriptional targeting of adenoviral vector through the CXCR4 tumor-specific promoter
  Z. B. Zhu, Sharmila K. Makhija, Baogen Lu, M. Wang, Lyudmila N. Kaliberova, Bin Liu, Angel A. Rivera, Dirk M. Nettelbeck, Parameshwar J. Mahasreshti, Charles A. Leath,...> ;Gene Therapy. 2004 Apr 1
• 20 citations
  Identification of genetic alterations related to chemoresistance in epithelial ovarian cancer
  Sharmila K. Makhija, Anita S.Y. Sit, Robert Edwards, K Aufman, H Weiss, A Kanbour-Shakir, William E. Gooding, Gina D'Angelo, Robert E. Ferrell, Siva Raja, Tony E. Godfrey> ;Gynecologic Oncology. 2003 Jul 1
• 137 citations
  Synergistic induction of tumor cell apoptosis by death receptor antibody and chemotherapy agent through JNK/p38 and mitochondrial death pathway.
  Toshiaki Ohtsuka, Donald J. Buchsbaum, Patsy G. Oliver, Sharmila K. Makhija, Robert P. Kimberly, Tong Zhou> ;Oncogene. 2003 Apr 3
• 88 citations
  Positron Emission Tomography/Computed Tomography Imaging for the Detection of Recurrent Ovarian and Fallopian Tube Carcinoma: A Retrospective Review
  Sharmila K. Makhija, N. Howden, R. Edwards, John M. Kelley, David W. Townsend, C.C. Meltzer> ;Gynecologic Oncology. 2002 Apr 1
• Join now to see all